课题基金 / 基金详情

MECHANISM OF SYNTHETIC RIBOZYME ACTION

MECHANISM OF SYNTHETIC RIBOZYME ACTION
合成核酶的作用机制
批准号:
2182941
负责人:
PETER T GILHAM
金额:
$16.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-09 至 1999-06-30

项目摘要

项目成果

PETER T GILHAM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) This proposal seeks to continue studies on ribozymes with non-cleavable internucleotide linkages and to exploit particular chemical modifications in internucleotide linkages in the study and development of new therapeutic agents that are aimed at specific target sequences in nucleic acids as a mechanism for the control of diseases. The modifications are "in-line" backbone changes in which the phosphodiester is converted to either a phosphono(5')methylene or phosphono(3')methylene linkage by substituting a methylene group for the 5'-oxygen or 3'-oxygen, respectively. This proposal is based on the following recent observations (1) The ADP and ATP analogues in which the 5'-oxygens are replaced with methylene groups serve as substrates for polynucleotide phosphorylase and phage T3 RNA polymerase, respectively. (2) Oligonucleotides containing all phosphono(5')methylene linkages appear to be isosteric with their natural counterparts in that they are able to participate in triple strand formation. (3) Because of the presence of the P-C bond, oligomers containing such linkages are completely resistant to the types of chemical and nuclease cleavage that involve breakage between the phosphorous and the 5'-oxygen in their natural counterparts. In-depth chemical, physical, enzymatic and biological studies will be performed on mononucleotides, oligonucleotide and nucleic acid analogues containing phosphonomethylene linkages. In addition substitution of a phosphono(5')methylene linkage at the cleavage point in a ribozyme substrate should permit formation of the ribozyme's active conformation without risk of its self-destruction during analysis. A second special application concerns the potential use of the mononucleotide analogues themselves as therapeutic drugs and it seems likely that one or more of the ribo- and deoxyribo-nucleoside triphosphate analogues containing a methylene group in place of the 5'-hydroxyl will be found to serve a substrates for one or more of the human polymerases (including reverse transcriptase).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISM OF SYNTHETIC RIBOZYME ACTION
  • 批准号:
    3304454
  • 项目类别:
  • 资助金额:
    $14.54万
  • 财政年份:
    1990
  • 负责人:
    PETER T GILHAM
  • 依托单位:
MECHANISM OF SYNTHETIC RIBOZYME ACTION
  • 批准号:
    2182942
  • 项目类别:
  • 资助金额:
    $17.46万
  • 财政年份:
    1990
  • 负责人:
    PETER T GILHAM
  • 依托单位:
MECHANISM OF SYNTHETIC RIBOZYME ACTION
  • 批准号:
    3304451
  • 项目类别:
  • 资助金额:
    $12.62万
  • 财政年份:
    1990
  • 负责人:
    PETER T GILHAM
  • 依托单位:
MECHANISM OF SYNTHETIC RIBOZYME ACTION
  • 批准号:
    2770969
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    1990
  • 负责人:
    PETER T GILHAM
  • 依托单位:
海外基金